This website is in development mode! We will live soon... Please stay with AmirNFT.com

Quanterix Corp

QTRX: Quanterix Corp

Last Updated: 6/29/2025

Sector: Healthcare  Industry: Medical Devices  Web: -  

Country: United States  Exchange: -  Currency: USD  

Price6.65

Change1.22

P/E

PEG

P/B0.82

P/FCF

Debt Equity0.12

ROE-14.51

EPS this Year

EPS Past 5 Year

Quanterix Corp is a United States stock which is enlisted in the - stock exchange. It is the recommendation by the NASDAQ to Strong Buy  this item. But the investor should follow his won judgment and analytics to make the final decision.  Bellow are some related information, news and updates related to the company.

Strong Buy

Stock

NASDAQ

price
6.65
change
1.22%
Market Cap
886729246
Earnings
May 12/a
Dividend
-
P/E
-
Forward P/E
-
PEG
-
P/S
1.9
P/B
0.82
P/C
0.97
P/FCF
-
Quick Ratio
7.53
Current Ratio
8.29
Debt/Eq
0.12
LT Debt/Eq
0.1
SMA5
-
SMA20
11.8%
SMA200
-26.81%
EPS this Y
-
EPS next Y
-
EPS past 5Y
-
EPS next 5Y
-
Sales past 5Y
-
Insider Own
15.62%
Insider Trans
9.15%
Inst Own
93.76%
Inst Trans
-0.79%
ROA
-11.81%
ROE
-14.51%
ROI
-
Gross Margin
62.31%
Operating Margin
-44.4%
Profit Margin
-35.28%
Share Outstanding
-
Outstanding
38.80M
52W High
-60.27%
52W Low
64.2%
Avg. Volume
781.52K
Real Volume
1.82
Volume
1
Perf Week
8.66%
Perf Month
25.95%
Perf Quarter
-1.77%
Perf Half Y
-37.56%
Perf Year
-47.56%
Perf YTD
-37.44%
Beta
1.1
ATR
0.52
Volatility Week
-
Volatility Month
8.94
Quanterix Expands Reach with IVD and Large Reference Labs

Monday, June 23, 2025

Quanterix Expands Reach with I

BILLERICA, Mass., June 23, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that the HD-X Simoa Immunoassa

Insider Spends US$1.1m Buying More Shares In Quanterix

Thursday, June 12, 2025

Insider Spends US$1.1m Buying

Quanterix Corporation ( NASDAQ:QTRX ) shareholders (or potential shareholders) will be happy to see that the...

Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders

Wednesday, June 11, 2025

Kent Lake Condemns Quanterix's

Kent Lake PR LLC ("Kent Lake"), a holder of approximately 6.9% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), today issued the following statem

Transcript : Quanterix Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 01

Monday, June 9, 2025

Transcript : Quanterix Corpora

Presenter SpeechMatthew Sykes All right. Great. Good afternoon, everyone. I'm Matt Sykes, the life science tools and diagnostics analyst at Goldman Sachs, and I have the pleasure of having Masoud...

Quanterix to Present at Goldman Sachs Global Healthcare Conference

Friday, June 6, 2025

Quanterix to Present at Goldma

BILLERICA, Mass., June 06, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Execu

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

Friday, May 23, 2025

Kent Lake Responds to Quanteri

Kent Lake PR LLC ("Kent Lake"), a holder of approximately 6.9% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), today issued the following statem

Kent Lake Provides Information to Shareholders of Quanterix Corporation

Friday, May 23, 2025

Kent Lake Provides Information

On May 23, 2025, Kent Lake PR LLC announced that it has issued a statement regarding the Quanterix Corporation?s Post-Effective Amendment to its S-4 registration statement and Akoya Biosciences?...

3 Penny Stocks With Market Caps As Low As $70M To Watch

Thursday, May 22, 2025

3 Penny Stocks With Market Cap

As the U.S. market experiences a slight rebound from recent sell-offs, investors are keeping a close eye on federal deficit concerns and fluctuating bond yields. For those interested in exploring smal

Quanterix: Hard To Make A Good Diagnosis

Wednesday, May 14, 2025

Quanterix: Hard To Make A Good

Quanterix's Akoya acquisition sparks concerns over losses and stalled growth, impacting shares. Click here for a full investment analysis.

Quanterix Corp (QTRX) Q1 2025 Earnings Call Highlights: Record Consumables Revenue Amidst ...

Tuesday, May 13, 2025

Quanterix Corp (QTRX) Q1 2025

Quanterix Corp (QTRX) reports a strong quarter for consumables but faces revenue growth hurdles and market pressures.

Quanterix Corporation (QTRX) Q1 2025 Earnings Call Transcript

Monday, May 12, 2025

Quanterix Corporation (QTRX) Q

Quanterix Corporation (NASDAQ:QTRX) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ETCompany ParticipantsJoshua Young - Head, IRMasoud Toloue -...

Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates

Monday, May 12, 2025

Quanterix Corporation (QTRX) R

Quanterix (QTRX) delivered earnings and revenue surprises of 23.19% and 8.99%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Quanterix Corporation 2025 Q1 - Results - Earnings Call Presentation

Monday, May 12, 2025

Quanterix Corporation 2025 Q1

The following slide deck was published by Quanterix Corporation in conjunction with their 2025 Q1 earnings call.

Quanterix Releases Financial Results for the First Quarter of 2025

Monday, May 12, 2025

Quanterix Releases Financial R

BILLERICA, Mass., May 12, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the firs

Quanterix : Q1 2025 Earnings Presentation

Monday, May 12, 2025

Quanterix : Q1 2025 Earnings P

‌First Quarter 2025 Earnings M a y 1 2, 20 25 ...

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

Monday, May 5, 2025

Quanterix To Report First Quar

BILLERICA, Mass., May 05, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference

Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders

Wednesday, April 30, 2025

Kent Lake Issues Statement on

RINCON, Puerto Rico, April 30, 2025--Kent Lake PR LLC ("Kent Lake"), a holder of approximately 7.7% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTR

Quanterix, Akoya Biosciences Amend Merger Deal

Tuesday, April 29, 2025

Quanterix, Akoya Biosciences A

Quanterix (QTRX) and Akoya Biosciences (AKYA) said Tuesday they updated the terms of their previousl

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

Tuesday, April 29, 2025

Quanterix and Akoya Bioscience

BILLERICA, Mass. & MARLBOROUGH, Mass., April 29, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (

Strong week for Quanterix (NASDAQ:QTRX) shareholders doesn't alleviate pain of five-year loss

Tuesday, April 29, 2025

Strong week for Quanterix (NAS

It's nice to see the Quanterix Corporation ( NASDAQ:QTRX ) share price up 18% in a week. But will that repair the...

Quanterix : Amends Agreement with Akoya

Tuesday, April 29, 2025

Quanterix : Amends Agreement w

Amended Merger Agreement Synergistic Combination Delivering Compelling Strategic and Financial Benefits and Long-Term Value for Stockholders April 2025 ...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RKDA, CKPT, QTRX on Behalf of Shareholders

Tuesday, April 22, 2025

SHAREHOLDER INVESTIGATION: Hal

NEW YORK, April 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Thursday, April 17, 2025

Kent Lake Files Definitive Pro

RINCON, Puerto Rico, April 17, 2025--Kent Lake PR LLC ("Kent Lake"), a holder of approximately 7.7% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTR

Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya

Monday, April 7, 2025

Kent Lake Comments on Quanteri

RINCON, Puerto Rico, April 07, 2025--Kent Lake PR LLC ("Kent Lake") is a holder of approximately 7.5% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: Q

Quanterix: Still Many, Many Questions

Wednesday, April 2, 2025

Quanterix: Still Many, Many Qu

Quanterix sees growth with Akoya acquisition, but rising losses and investor skepticism persist. Explore challenges and insights on QTRX's stock performance.

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

Tuesday, April 1, 2025

Quanterix Showcases Innovation

BILLERICA, Mass., April 01, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the inclusion of a new dried

Quanterix Corp - On March 24, Appointed William P. Donnelly As Chairman - SEC Filing

Friday, March 28, 2025

Quanterix Corp - On March 24,

Quanterix Corp: * QUANTERIX CORP - ON MARCH 24, APPOINTED WILLIAM P.DONNELLY ASCHAIRMAN - SEC FILINGSource text:Further company coverage: ...

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

Wednesday, March 19, 2025

SERA PROGNOSTICS ANNOUNCES APP

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today a

Quanterix Full Year 2024 Earnings: EPS Misses Expectations

Wednesday, March 19, 2025

Quanterix Full Year 2024 Earni

Quanterix ( NASDAQ:QTRX ) Full Year 2024 Results Key Financial Results Revenue: US$137.4m (up 12% from FY 2023). Net...

Q4 2024 Quanterix Corp Earnings Call

Tuesday, March 18, 2025

Q4 2024 Quanterix Corp Earning

Q4 2024 Quanterix Corp Earnings Call

Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges

Tuesday, March 18, 2025

Quanterix Corp (QTRX) Q4 2024

Quanterix Corp (QTRX) reports an 11% revenue increase and improved margins, while navigating market volatility and strategic acquisitions.

Quanterix Releases Financial Results for the Fourth Quarter of 2024

Monday, March 17, 2025

Quanterix Releases Financial R

BILLERICA, Mass., March 17, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the fo

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

Monday, March 17, 2025

Akoya Reports Fourth Quarter o

MARLBOROUGH, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the fourth quarter and

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call

Monday, March 17, 2025

Kent Lake Urges Quanterix Mana

RINCON, Puerto Rico, March 17, 2025--Kent Lake PR LLC ("Kent Lake") is a holder of 7.47% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX). Kent La

Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript

Monday, March 17, 2025

Quanterix Corporation (QTRX) Q

Quanterix Corporation (NASDAQ:QTRX) Q4 2024 Earnings Conference Call March 17, 2025 4:30 PM ETCompany ParticipantsJoshua Young - Head of IRMasoud Toloue -...

Quanterix Corporation 2024 Q4 - Results - Earnings Call Presentation

Monday, March 17, 2025

Quanterix Corporation 2024 Q4

The following slide deck was published by Quanterix Corporation in conjunction with their 2024 Q4 earnings call.

Kent Lake urges Quanterix to address questions regarding Akoya deal

Monday, March 17, 2025

Kent Lake urges Quanterix to a

Quanterix Corp: * KENT LAKE URGES QUANTERIX MANAGEMENT TO ADDRESS KEYQUESTIONSREGARDING ITS PROPOSED TRANSACTION WITH AKOYA BIOSCIENCES DURINGTODAY’S EARNINGS CALL *...

Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Thursday, March 13, 2025

Quanterix To Report Fourth Qua

BILLERICA, Mass., March 13, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conferenc

Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger

Tuesday, March 11, 2025

Quanterix Shareholder Opposes

Quanterix (QTRX) shareholder Kent Lake said Tuesday that it opposes the company's proposed deal with

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences

Tuesday, March 11, 2025

Kent Lake Issues Investor Pres

RINCON, Puerto Rico, March 11, 2025--Kent Lake PR LLC ("Kent Lake") a holder of 7.25% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), today issu

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Monday, March 3, 2025

Kent Lake Nominates Three High

RINCON, Puerto Rico, March 03, 2025--Kent Lake PR LLC ("Kent Lake"), a holder of 6.9% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), announced

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

Monday, March 3, 2025

Quanterix Highlights Compellin

BILLERICA, Mass., March 03, 2025--Quanterix Corporation (NASDAQ: QTRX) ("Quanterix" or the "Company"), a company fueling scientific discovery through ultra-sensitive biomarker detection, today reitera

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences

Tuesday, February 18, 2025

Kent Lake Issues Letter to Qua

RINCON, Puerto Rico, February 18, 2025--Kent Lake PR LLC ("Kent Lake"), a holder of 5.9% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), today h

Bullish Quanterix Insiders Loaded Up On US$831.7k Of Stock

Thursday, February 13, 2025

Bullish Quanterix Insiders Loa

Multiple insiders secured a larger position in Quanterix Corporation ( NASDAQ:QTRX ) shares over the last 12 months...

QTRX Investor News: Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX

Tuesday, January 28, 2025

QTRX Investor News: Rosen Law

NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor...

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quanterix Corporation - QTRX

Tuesday, January 28, 2025

Pomerantz Law Firm Investigate

NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Quanterix Corporation . Such investors are advised to contact Danielle Peyton at...

Transcript : Quanterix Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 04

Wednesday, January 15, 2025

Transcript : Quanterix Corpora

Presenter SpeechUnknown Analyst All right. Good afternoon, everybody. Welcome to the 43rd JPMorgan Healthcare Conference. It is my pleasure today to introduce Quanterix with us today for the...

Quanterix Provides Update on Financial Performance

Tuesday, January 14, 2025

Quanterix Provides Update on F

BILLERICA, Mass., January 14, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced selected preliminary, unaud

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ACCD, ESSA, QTRX on Behalf of Shareholders

Monday, January 13, 2025

SHAREHOLDER INVESTIGATION: Hal

NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches.

Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX

Monday, January 13, 2025

Rosen Law Firm Encourages Quan

NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor...

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood and Tissue-Based Protein Biomarkers

Monday, January 13, 2025

Quanterix to Acquire Akoya Bio

BILLERICA, MARLBOROUGH - Quanterix Corporation , a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences , The Spatial Biology Company, today...

Quanterix: Why Pursuing A Big Deal For Akoya?

Saturday, January 11, 2025

Quanterix: Why Pursuing A Big

Read here for an analysis of Quanterix's volatile journey post-IPO, facing losses, compliance issues, and backlash from their acquisition of Akoya Biosciences.

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ESSA, AKYA, CCNE, QTRX on Behalf of Shareholders

Friday, January 10, 2025

SHAREHOLDER NOTICE: Halper Sad

NEW YORK, Jan. 10, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches.

Quanterix Agrees to Acquire Akoya Biosciences in All-Stock Deal

Friday, January 10, 2025

Quanterix Agrees to Acquire Ak

Quanterix (QTRX) and Akoya Biosciences (AKYA) said Friday they entered into a definitive merger agre

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

Friday, January 10, 2025

Quanterix to Acquire Akoya Bio

BILLERICA, Mass. and MARLBOROUGH, Mass., January 10, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Bioscienc

Quanterix : to Acquire Akoya Biosciences Presentation

Friday, January 10, 2025

Quanterix : to Acquire Akoya B

First Integrated Solution for Ultra- Sensitive Detection of Blood and Tissue Based Protein Biomarkers Uniquely positioned to speed up market development of new diagnostic testing...

QTRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Quanterix Corporation Is Fair to Shareholders

Friday, January 10, 2025

QTRX Stock Alert: Halper Sadeh

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Quanterix Corporation and Akoya Biosciences, Inc. is fair to Quanterix shareholders. Upon completion of the...

Quanterix Corporation - David R. Walt Receives National Medal of Technology and Innovation

Tuesday, January 7, 2025

Quanterix Corporation - David

BILLERICA - Quanterix Corporation , a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that David R. Walt, co-inventor of the Company's Simoa technology

David R. Walt Receives National Medal of Technology and Innovation

Monday, January 6, 2025

David R. Walt Receives Nationa

BILLERICA, Mass., January 06, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that David R. Walt, co-inve

Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Thursday, January 2, 2025

Quanterix to Present at the 43

BILLERICA, Mass., January 02, 2025--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Ex

ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation - QTRX

Tuesday, December 31, 2024

ROSEN, A LEADING AND LONGSTAND

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Quanterix Corporation resulting from allegations that...

Down More Than 60%: Analysts Expect These 2 Beaten-Down Stocks to Rebound in 2025

Friday, December 27, 2024

Down More Than 60%: Analysts E

Building up a strong portfolio requires a sharp eye for bargains. Investors have to know how to find the right stocks, at the right price – i.e. shares that are priced relatively low, but have sound p

Quanterix : Amendment to Annual Report (Form 10-K/A)

Thursday, December 26, 2024

Quanterix : Amendment to Annua

qtrx-20231231 Table of Contents UNITED STATES ...

Quanterix : Amendment to Quarterly Report (Form 10-Q/A)

Thursday, December 26, 2024

Quanterix : Amendment to Quart

qtrx-20240630 Table of Contents UNITED STATES ...

Quanterix : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)

Thursday, December 26, 2024

Quanterix : Quarterly Report f

qtrx-20240930 Table of Contents UNITED STATES ...

Quanterix : Expands Capabilities with Strategic Acquisition of EMISSION Form 8 K

Tuesday, December 17, 2024

Quanterix : Expands Capabiliti

Quanterix Expands Capabilities with Strategic Acquisition of EMISSION Builds technology capabilities through vertical integration of proprietary bead technology and drives OEM...

Quanterix Expands Capabilities with Strategic Acquisition of EMISSION

Tuesday, December 17, 2024

Quanterix Expands Capabilities

BILLERICA, Mass., December 17, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announc

INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Qaunterix Corporation (NASDAQ

Wednesday, December 4, 2024

INVESTIGATION NOTICE: Girard S

SAN FRANCISCO, Dec. 04, 2024 -- Girard Sharp, LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of Qaunterix Corporation...

Quanterix Announces Receipt of Expected Notice from Nasdaq

Friday, November 22, 2024

Quanterix Announces Receipt of

BILLERICA, Mass., November 22, 2024--Quanterix Corporation (NASDAQ: QTRX) today announced that it received a notice (the "Notice") on November 21, 2024 from The Nasdaq Stock Market LLC ("Nasdaq") stat

Quanterix : Announces Receipt of Expected Notice from Nasdaq Form 8 K

Friday, November 22, 2024

Quanterix : Announces Receipt

Quanterix Announces Receipt of Expected Notice from Nasdaq BILLERICA, Mass.-November 22, 2024 - Quanterix Corporation today announced that it received a notice on November 21, 2024...

QTRX Investors Have Opportunity to Join Quanterix Corporation Fraud Investigation with the Schall Law Firm

Friday, November 22, 2024

QTRX Investors Have Opportunit

LOS ANGELES, Nov. 22, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation

Rosen Law Firm Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation – QTRX

Thursday, November 21, 2024

Rosen Law Firm Encourages Quan

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Quanterix Corporation resulting from allegations that...

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Quanterix Corporation for potential violations of securities laws

Thursday, November 21, 2024

Wolf Haldenstein Adler Freeman

PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION  NEW YORK, Nov. 21, 2024 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP , a preeminent national shareholder rights litigation fir...

Alzheimer's Diagnostic Blood Test Now Available in the UK

Monday, November 18, 2024

Alzheimer's Diagnostic Blood T

Advance Tests Launches the LucentAD Complete Test, Bringing New Standards of Alzheimer's Detection and Accessibility to the UKLondon - Advance Tests, a pioneer in advanced diagnostics, today...

Law Offices of Howard G. Smith Announces Investigation of Quanterix Corporation (QTRX) on Behalf of Investors

Wednesday, November 13, 2024

Law Offices of Howard G. Smith

Law Offices of Howard G. Smith announces an investigation on behalf of Quanterix Corporation investors concerning the Company’s possible violations of federal securities laws.On November 12,...

The Law Offices of Frank R. Cruz Announces Investigation of Quanterix Corporation (QTRX) on Behalf of Investors

Wednesday, November 13, 2024

The Law Offices of Frank R. Cr

The Law Offices of Frank R. Cruz announces an investigation of Quanterix Corporation on behalf of investors concerning the Company’s possible violations of federal securities laws.If you are a...

Quanterix Corp (QTRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Instrument ...

Wednesday, November 13, 2024

Quanterix Corp (QTRX) Q3 2024

Quanterix Corp (QTRX) reports its sixth consecutive quarter of double-digit revenue growth, despite facing hurdles in instrument sales and regional revenue declines.

Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024

Tuesday, November 12, 2024

Quanterix Releases Preliminary

BILLERICA, Mass., November 12, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced preliminary financial res

Quanterix Corporation (QTRX) Q3 2024 Earnings Conference Call Transcript

Tuesday, November 12, 2024

Quanterix Corporation (QTRX) Q

Quanterix Corporation (NASDAQ:QTRX) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ETCompany ParticipantsVandana Sriram - CFOMasoud Toloue -...

Quanterix : Releases Preliminary Financial Results for the Third Quarter of 2024 Form 8 K

Tuesday, November 12, 2024

Quanterix : Releases Prelimina

Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024 Sixth Consecutive Quarter of Double-Digit Growth Reaffirms Full Year 2024 Outlook ...

Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024

Tuesday, November 5, 2024

Quanterix To Report Third Quar

BILLERICA, Mass., November 05, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a confer

Quanterix : Statement of Changes in Beneficial Ownership - Form 4

Thursday, October 31, 2024

Quanterix : Statement of Chang

Ownership Submission FORM 4 Check this box if no longer...

Quanterix Corp (QTRX) Shares Up 6.45% on Oct 29

Tuesday, October 29, 2024

Quanterix Corp (QTRX) Shares U

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix (QTRX) Gets a Buy from Leerink Partners

Tuesday, October 29, 2024

Quanterix (QTRX) Gets a Buy fr

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer’s Disease Diagnostic Information

Monday, October 28, 2024

New Multi-Marker Blood Test fr

BILLERICA, Mass., October 28, 2024--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has introduced LucentAD Complete, a new multi-marker blood test designed to help detect Alzheim

Lucent introduces LucentAD Complete multi-marker blood test

Monday, October 28, 2024

Lucent introduces LucentAD Com

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix Corp (QTRX) Trading Down 3.35% on Oct 23

Wednesday, October 23, 2024

Quanterix Corp (QTRX) Trading

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Leerink Partners Reaffirms Their Buy Rating on Quanterix (QTRX)

Monday, October 14, 2024

Leerink Partners Reaffirms The

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix Corp (QTRX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amid Regional ...

Wednesday, October 9, 2024

Quanterix Corp (QTRX) Q2 2024

Quanterix Corp (QTRX) reports an 11% revenue increase, driven by Accelerator Lab growth, despite a decline in instrument sales and Asia Pacific challenges.

Quanterix Corp (QTRX) Stock Price Down 3.03% on Oct 7

Monday, October 7, 2024

Quanterix Corp (QTRX) Stock Pr

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix : Amendment to Current Report Form 8 K/A

Friday, October 4, 2024

Quanterix : Amendment to Curre

qtrx-20240819 UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...

Quanterix : Welcomes Ivana Magovčević Liebisch, Ph.D., J.D. to Board of Directors Form 8 K

Thursday, October 3, 2024

Quanterix : Welcomes Ivana Mag

Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors BILLERICA, Mass. - October 2, 2024 - Quanterix Corporation , a company fueling...

Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors

Wednesday, October 2, 2024

Quanterix Welcomes Ivana Magov

BILLERICA, Mass., October 02, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announce

Brainsway (BWAY) Soars 14.5%: Is Further Upside Left in the Stock?

Tuesday, October 1, 2024

Brainsway (BWAY) Soars 14.5%:

Brainsway (BWAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Quanterix Announces Commercialization of p-Tau 217 Test Kit

Monday, September 30, 2024

Quanterix Announces Commercial

BILLERICA, Mass., September 30, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announ

Closing Bell Movers: IGM Biosciences down 20% on strategic pivot

Monday, September 30, 2024

Closing Bell Movers: IGM Biosc

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Leerink sees preliminary CLFS determinations as a negative for Quanterix

Thursday, September 26, 2024

Leerink sees preliminary CLFS

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

CMS publishes preliminary CLFS determinations for new codes

Thursday, September 26, 2024

CMS publishes preliminary CLFS

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Exact Sciences, Quanterix extend slide after Medicare rates

Thursday, September 26, 2024

Exact Sciences, Quanterix exte

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix Corp (QTRX) Trading Down 2.85% on Sep 23

Monday, September 23, 2024

Quanterix Corp (QTRX) Trading

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix Corp (QTRX) Trading Down 3.55% on Sep 20

Friday, September 20, 2024

Quanterix Corp (QTRX) Trading

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix Corp (QTRX) Shares Up 3.33% on Sep 18

Wednesday, September 18, 2024

Quanterix Corp (QTRX) Shares U

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Closing Bell Movers: Intuitive Machines up over 40% on NASA contract

Tuesday, September 17, 2024

Closing Bell Movers: Intuitive

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix director buys $624.6K in common stock

Tuesday, September 17, 2024

Quanterix director buys $624.6

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Shareholders in Quanterix (NASDAQ:QTRX) are in the red if they invested three years ago

Monday, September 16, 2024

Shareholders in Quanterix (NAS

As every investor would know, not every swing hits the sweet spot. But really bad investments should be rare. So...

Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference

Thursday, August 29, 2024

Quanterix to Participate at th

BILLERICA, Mass., August 29, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer

Quanterix Corporation: Still Struggling To Gain Traction

Monday, August 26, 2024

Quanterix Corporation: Still S

Quanterix Corporation shows promise in healthcare technology, with steady revenue growth and a focus on early Alzheimer's detection. Click here for my QTRX update.

Masoud Toloue Bought 11% More Shares In Quanterix

Tuesday, August 20, 2024

Masoud Toloue Bought 11% More

Potential Quanterix Corporation ( NASDAQ:QTRX ) shareholders may wish to note that the President, Masoud Toloue...

Jeffrey Elliott Appointed to Quanterix's Board of Directors

Tuesday, August 20, 2024

Jeffrey Elliott Appointed to Q

BILLERICA, Mass. - Quanterix Corporation , a company fueling scientific discovery and breakthrough diagnostics through ultra-sensitive biomarker detection, today announced that it appointed Jeffrey...

Jeffrey Elliott Appointed to Quanterix’s Board of Directors

Monday, August 19, 2024

Jeffrey Elliott Appointed to Q

BILLERICA, Mass., August 19, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultra-sensitive biomarker detection, today announce

Jeffrey Elliott Appointed to Quanterix?s Board of Directors

Monday, August 19, 2024

Jeffrey Elliott Appointed to Q

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Insider Buying: President & CEO Masoud Toloue Acquires Shares of Quanterix Corp (QTRX)

Thursday, August 15, 2024

Insider Buying: President & CE

Following this transaction, the insider now owns a total of 354,119 shares of Quanterix Corp. Quanterix Corp is a company that specializes in the development of ultra-sensitive digital immunoassay pl

Invesco Small Cap Equity Fund Q2 2024 Review

Thursday, August 15, 2024

Invesco Small Cap Equity Fund

Invesco Small Cap Equity Fund outperformed the Russell 2000 Index in the second quarter of 2024. Click here to read the full fund letter.

Analysts Offer Insights on Healthcare Companies: Quanterix (QTRX), Doximity (DOCS) and Warby Parker (WRBY)

Tuesday, August 13, 2024

Analysts Offer Insights on Hea

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix price target lowered by $4 at Scotiabank, here's why

Monday, August 12, 2024

Quanterix price target lowered

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Scotiabank Keeps Their Buy Rating on Quanterix (QTRX)

Monday, August 12, 2024

Scotiabank Keeps Their Buy Rat

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix Corporation (NASDAQ:QTRX) Just Reported, And Analysts Assigned A US$22.00 Price Target

Sunday, August 11, 2024

Quanterix Corporation (NASDAQ:

As you might know, Quanterix Corporation ( NASDAQ:QTRX ) just kicked off its latest quarterly results with some very...

Quanterix Second Quarter 2024 Earnings: Beats Expectations

Saturday, August 10, 2024

Quanterix Second Quarter 2024

Quanterix ( NASDAQ:QTRX ) Second Quarter 2024 Results Key Financial Results Revenue: US$34.4m (up 11% from 2Q 2023...

Quanterix Corporation (QTRX) Q2 2024 Earnings Call Transcript

Friday, August 9, 2024

Quanterix Corporation (QTRX) Q

Quanterix Corporation (NASDAQ:NASDAQ:QTRX) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ETCompany ParticipantsFrancis Pruell - Head, IRMasoud...

Quanterix price target lowered by $2 at TD Cowen, here's why

Friday, August 9, 2024

Quanterix price target lowered

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix price target lowered by $5 at Canaccord, here's why

Friday, August 9, 2024

Quanterix price target lowered

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates

Thursday, August 8, 2024

Quanterix Corporation (QTRX) R

Quanterix (QTRX) delivered earnings and revenue surprises of -8.70% and 0.56%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Quanterix Releases Financial Results for the Second Quarter of 2024

Thursday, August 8, 2024

Quanterix Releases Financial R

BILLERICA, Mass., August 08, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the s

Hold Rating on Quanterix Amid Modest Sales Performance and Market Uncertainty

Thursday, August 8, 2024

Hold Rating on Quanterix Amid

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Here is the next potential market catalyst

Thursday, August 8, 2024

Here is the next potential mar

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q2 2024

Thursday, August 8, 2024

QTRX Stock Earnings: Quanterix

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix Corp (QTRX) Q2 2024 Earnings: EPS of -$0.25 Beats Estimates, Revenue of $34. ...

Thursday, August 8, 2024

Quanterix Corp (QTRX) Q2 2024

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix GAAP EPS of -$0.25 beats by $0.01, revenue of $34.38M beats by $0.75M

Thursday, August 8, 2024

Quanterix GAAP EPS of -$0.25 b

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix cuts FY24 revenue view to $134M-$138M from $139M-$144M

Thursday, August 8, 2024

Quanterix cuts FY24 revenue vi

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix reports Q2 EPS (25c), consensus (26c)

Thursday, August 8, 2024

Quanterix reports Q2 EPS (25c)

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference

Tuesday, August 6, 2024

Quanterix Presenting at Canacc

BILLERICA, Mass., August 06, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced that Chief Executive Office

Quanterix To Report Second Quarter 2024 Financial Results

Wednesday, July 31, 2024

Quanterix To Report Second Qua

BILLERICA, Mass., July 31, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference

Ayr Wellness Inc. (AYRWF) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Wednesday, July 31, 2024

Ayr Wellness Inc. (AYRWF) Expe

Ayr Wellness Inc. (AYRWF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's Driving Avanos Medical Inc's Surprising 34% Stock Rally?

Wednesday, July 31, 2024

What's Driving Avanos Medical

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Buy Recommendation for Quanterix Amid Strong Prospects in Alzheimer’s Diagnostics

Tuesday, July 30, 2024

Buy Recommendation for Quanter

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for

Monday, July 29, 2024

Analysts Estimate Quanterix Co

Quanterix (QTRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer’s Disease Detection that is More Effective than Standalone Plasma p-Tau 217

Monday, July 29, 2024

Quanterix Presents Data Demons

BILLERICA, Mass., July 29, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today presented new data at the Alzheimer’s As

One Quanterix Insider Raised Their Stake In The Previous Year

Monday, July 29, 2024

One Quanterix Insider Raised T

From what we can see, insiders were net buyers in Quanterix Corporation's ( NASDAQ:QTRX ) during the past 12 months...

Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer?s Disease Detection that is More Effective than Standalone Plasma p-Tau 217

Monday, July 29, 2024

Quanterix Presents Data Demons

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quanterix presents new Alzheimer's disease data at AAIC

Monday, July 29, 2024

Quanterix presents new Alzheim

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.